Health
Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward – TCTMD
DREAM-HF provides hints of an anti-inflammatory effect and benefits beyond the heart, setting up future trials.
Targeted injection of mesenchymal precursor cells (MPCs) into the myocardium is safe but does not reduce recurrent nonfatal decompensated heart failure (HF) events in patients with chronic HF with reduced ejection fraction (HFrEF), the randomized DREAM-HF…
Continue Reading
-
Noosa News19 hours agoDangerous storm pounds south-east Queensland with giant hail, blackouts and widespread damage
-
Noosa News22 hours agoBruce Highway fatal: Grandmother’s heartbreak as daughter and granddaughter killed in Queensland truck crash
-
General6 hours agoVictorian government blocked fire service from pursuing US giant over PFAS contamination
-
Business22 hours agoWhy Gentrack, Monash IVF, Pro Medicus, and Qube shares are racing higher today